On August 30, 2018 Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on novel therapies in oncology, reported that senior management will present at the following upcoming investor conferences (Press release, Immune Design, AUG 30, 2018, View Source [SID1234529181]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
13th Annual Wells Fargo Securities Healthcare Conference
Wednesday, September 5, 2018 at 1:50 p.m. Eastern Time in Boston.
H.C. Wainwright & Co. 20th Annual Global Investment Conference
Thursday, September 6, 2018 at 10:50 a.m. Eastern Time in New York.
A live webcast of each presentation will be available online from the investor relations page of the company’s corporate website at View Source After the live webcast, an archive of each presentation will be available on the company website for 30 days.